サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1513680

線維芽細胞成長因子の世界市場：産業分析、規模、シェア、成長、動向、予測、2024～2033年

Fibroblast Growth Factors Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

出版日
ページ情報
英文 235 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
線維芽細胞成長因子の世界市場：産業分析、規模、シェア、成長、動向、予測、2024～2033年
出版日: 2024年07月10日
発行: Persistence Market Research
ページ情報: 英文 235 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

当レポートは、世界の線維芽細胞成長因子（FGFs）市場に関する包括的なレポートを発表しました。市場促進要因・動向・機会・課題を含む重要な市場力学を徹底的に評価し、市場構造に関する詳細な洞察を提供しています。

主要な洞察

  • 線維芽細胞成長因子の市場規模（2024年）：3億215万米ドル
  • 予測市場金額（2033年）：5億8,290万米ドル
  • 世界市場成長率（CAGR 2024～2033年）：7.6%

線維芽細胞成長因子市場 - 調査範囲：

線維芽細胞成長因子は、創傷治癒、組織再生、筋骨格系疾患の治療など、様々な医療用途において重要な役割を果たしています。これらの因子は細胞増殖、血管新生、分化を刺激し、病院、クリニック、研究機関など多様なヘルスケア環境において治療成果を促進します。市場成長の原動力は、研究活動の活発化、治療用途の拡大、バイオテクノロジー製造プロセスの進歩による製品の有効性と安全性の向上です。

市場成長の促進要因：

世界の線維芽細胞成長因子市場は、再生医療やバイオテクノロジー研究への投資の増加、高度な治療オプションを必要とする慢性疾患の有病率の増加、筋骨格系障害や慢性創傷を起こしやすい老人人口の増加など、いくつかの主要な要因によって推進されています。組換えDNA技術とタンパク質工学の技術的進歩は、治療特性を強化した新規FGF変異体の開発に貢献しており、市場拡大を牽引しています。

市場抑制要因：

有望な成長見込みがあるにもかかわらず、線維芽細胞成長因子市場は、規制当局の承認プロセス、バイオ医薬品開発に関連する高コスト、FGFベースの治療法の長期的な安全性と有効性に関する懸念に関連する課題に直面しています。生物製剤の製造、臨床試験、商業化を管理する厳しい規制の枠組みは、メーカーやヘルスケアプロバイダーにコンプライアンスの負担を課し、市場のダイナミクスや経営戦略に影響を与えます。

市場機会：

線維芽細胞成長因子市場は、個別化医療アプローチの採用拡大、創傷治療や組織工学への応用拡大、バイオ医薬品企業と学術研究機関の戦略的提携などを原動力とする大きな成長機会を示しています。徐放性製剤や生体材料をベースとした担体などのドラッグデリバリーシステムの革新は、治療成績と患者のコンプライアンスを向上させ、市場の成長と差別化を促進します。

本レポートで扱う主な質問

  • 線維芽細胞成長因子市場の世界的成長を促進する主な要因は何か？
  • 線維芽細胞成長因子市場の競合情勢を形成している治療用途とバイオテクノロジーの進歩は何か？
  • 線維芽細胞成長因子市場に貢献している主要企業はどこか、また、市場の主導権を維持するためにどのような戦略をとっているのか？
  • 世界の線維芽細胞成長因子市場における新たな動向と将来性は？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/分類
  • 市場の定義/範囲/制限
  • 包含と除外

第3章 主要な市場動向

  • 市場に影響を与える主な動向
  • 製品イノベーション/開発動向

第4章 付加価値のある洞察

  • 製品評価
    • 製品採用分析
    • 製品のUSP/機能分析
    • 最近の製品の発売とイノベーション
    • 製品マトリックス分析
  • 疾病疫学、主要国別
    • がん
    • 急性創傷と慢性創傷
    • パーキンソン病
  • 規制ガイドライン
  • ポーターの分析
  • PESTEL分析
  • バリューチェーン分析

第5章 市場背景

  • マクロ経済要因
  • 予測要因 - 関連性と影響
  • 市場力学

第6章 世界市場の需要（金額または規模、100万米ドル）分析

  • 過去の市場金額（100万米ドル）分析、2019～2023年
  • 現在および将来の市場金額（100万米ドル）予測、2024～2033年
    • 前年比成長動向分析
    • 絶対的ドル機会分析

第7章 世界市場分析、製品別

  • イントロダクション/主な調査結果
  • 過去の市場規模（100万米ドル）の分析、製品別、2019年～2023年
  • 現在および将来の市場規模（100万米ドル）分析と予測、製品別、2024～2033年
    • FGF1
    • FGF2
    • FGF3
    • FGF4
    • FGF7
    • FGF10
    • FGF11
    • FGF12
    • FGF13
    • FGF14
    • FGF15
    • FGF18
    • FGF19
    • FGF20
    • FGF23
    • その他
  • 市場魅力分析：製品別

第8章 世界市場分析、用途別

  • イントロダクション/主な調査結果
  • 過去の市場規模（100万米ドル）の分析、用途別、2019年～2023年
  • 現在および将来の市場規模（100万米ドル）分析と予測、用途別、2024～2033年
    • 腫瘍学
    • 血液学
    • 創傷治癒
    • 皮膚科
    • 心臓血管疾患・糖尿病
    • 細胞培養
    • その他
  • 市場魅力分析：用途別

第9章 世界市場分析、エンドユーザー別

  • イントロダクション/主な調査結果
  • 過去の市場規模（100万米ドル）の分析、エンドユーザー別、2019年～2023年
  • 現在および将来の市場規模（100万米ドル）分析と予測、エンドユーザー別、2024～2033年
    • 製薬・バイオテクノロジー企業
    • 研究センター・学術機関
    • CMO・CDMO
  • 市場魅力分析：エンドユーザー別

第10章 世界市場分析、地域別

  • イントロダクション/主な調査結果
  • 過去の市場規模（100万米ドル）の分析、地域別、2019年～2023年
  • 現在および将来の市場規模（100万米ドル）分析と予測、地域別、2024～2033年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジア
    • オセアニア
    • 中東・アフリカ
  • 市場魅力分析：地域別

第11章 北米の市場分析

第12章 ラテンアメリカの市場分析

第13章 欧州の市場分析

第14章 東アジアの市場分析

第15章 南アジアの市場分析

第16章 オセアニアの市場分析

第17章 中東・アフリカの市場分析

第18章 市場構造分析

  • 企業階層別市場分析
  • 主要企業の市場シェア分析
  • 市場集中
  • 市場プレゼンス分析

第19章 競合分析

  • 競合ダッシュボード
  • 主要開発分析
  • メーカーによるブランディングとプロモーション戦略
  • 競合の詳細
    • Thermo Fisher Scientific
    • Sigma-Aldrich（now part of Merck KGaA）
    • PeproTech
    • R&D Systems（a Bio-Techne brand）
    • Abcam
    • Cell Signaling Technology
    • Novus Biologicals

第20章 使用される仮定と頭字語

第21章 調査手法

目次
Product Code: PMRREP28315

Persistence Market Research has recently released a comprehensive report on the Fibroblast Growth Factors (FGFs) Market. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Fibroblast Growth Factors Market Size (2024E): USD 302.15 million
  • Projected Market Value (2033F): USD 582.9 million
  • Global Market Growth Rate (CAGR 2024 to 2033): 7.6%

Fibroblast Growth Factors Market - Report Scope:

Fibroblast Growth Factors play a crucial role in various medical applications, including wound healing, tissue regeneration, and treatment of musculoskeletal disorders. These factors stimulate cellular proliferation, angiogenesis, and differentiation, promoting therapeutic outcomes across diverse healthcare settings, including hospitals, clinics, and research institutions. Market growth is driven by increasing research activities, expanding therapeutic applications, and advancements in biotechnological manufacturing processes, enhancing product efficacy and safety profiles.

Market Growth Drivers:

The global Fibroblast Growth Factors market is propelled by several key factors, including growing investments in regenerative medicine and biotechnology research, increasing prevalence of chronic diseases necessitating advanced treatment options, and rising geriatric population prone to musculoskeletal disorders and chronic wounds. Technological advancements in recombinant DNA technology and protein engineering contribute to the development of novel FGF variants with enhanced therapeutic properties, driving market expansion.

Market Restraints:

Despite promising growth prospects, the Fibroblast Growth Factors market faces challenges related to regulatory approval processes, high costs associated with biopharmaceutical development, and concerns regarding long-term safety and efficacy of FGF-based therapies. Stringent regulatory frameworks governing the manufacturing, clinical trials, and commercialization of biologics impose compliance burdens on manufacturers and healthcare providers, influencing market dynamics and operational strategies.

Market Opportunities:

The Fibroblast Growth Factors market presents significant growth opportunities driven by increasing adoption of personalized medicine approaches, expanding applications in wound care and tissue engineering, and strategic collaborations between biopharmaceutical companies and academic research institutions. Innovations in drug delivery systems, such as sustained-release formulations and biomaterial-based carriers, enhance therapeutic outcomes and patient compliance, fostering market growth and differentiation.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Fibroblast Growth Factors market globally?
  • Which therapeutic applications and biotechnological advancements are shaping the competitive landscape of the Fibroblast Growth Factors market?
  • Who are the key players contributing to the Fibroblast Growth Factors market, and what strategies are they employing to maintain market leadership?
  • What are the emerging trends and future prospects in the global Fibroblast Growth Factors market?

Competitive Intelligence and Business Strategy:

Leading players in the global Fibroblast Growth Factors market, including Abcam,Novus Biologicals,PeproTech, focus on innovation, strategic partnerships, and regulatory compliance to gain a competitive edge. These companies invest in research and development to advance biotechnological platforms, expand therapeutic applications, and strengthen market presence. Collaborations with academic research centers and healthcare providers facilitate clinical development and market access, driving product differentiation and commercial success.

Key Companies Profiled:

  • Thermo Fisher Scientific
  • Sigma-Aldrich (now part of Merck KGaA)
  • PeproTech
  • R&D Systems (a Bio-Techne brand)
  • Abcam
  • Cell Signaling Technology
  • Novus Biologicals

Key Segments of Fibroblast Growth Factors Industry Research

Product:

  • FGF1
  • FGF2
  • FGF3
  • FGF4
  • FGF7
  • FGF10
  • FGF11
  • FGF12
  • FGF13
  • FGF14
  • FGF15
  • FGF18
  • FGF19
  • FGF20
  • FGF23

Application:

  • Oncology
  • Hematology
  • Wound Healing
  • Dermatology
  • Cardiovascular Disease & Diabetes
  • Cell Culture

End User:

  • Pharmaceutical & Biotechnology Companies
  • Research Centers & Academic Institutes
  • CMOs & CDMOs

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Value-Added Insights

  • 4.1. Product Assessment
    • 4.1.1. Product Adoption Analysis
    • 4.1.2. Product USP's/Features Analysis
    • 4.1.3. Recent Product Launches and Innovations
    • 4.1.4. Product Matrix Analysis
  • 4.2. Disease Epidemiology, By Key Countries
    • 4.2.1. Cancer
    • 4.2.2. Acute Wound and Chronic Wound
    • 4.2.3. Parkinson's Disease
  • 4.3. Regulatory Guidelines
  • 4.4. Porter's Analysis
  • 4.5. PESTEL Analysis
  • 4.6. Value Chain Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global Healthcare Expenditure
    • 5.1.2. Research and Development funding By Region
    • 5.1.3. Global Growth Factor Market Overview
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Key Player's Historic Growth
    • 5.2.2. Advancements In Manufacturing Technology
    • 5.2.3. Increasing Biopharmaceutical Production
    • 5.2.4. Strategic Collaborations Among Players
    • 5.2.5. Technical Benefits For Manufacturers And Suppliers
    • 5.2.6. Increasing Investments in R&D
    • 5.2.7. Increasing Adoption of Growth Factor in Medical Sciences
    • 5.2.8. Increasing Demand from Growth Factors
    • 5.2.9. Growing Adoption of Tissue Engineering
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. Global Market Demand (in Value or Size in US$ Million) Analysis 2019-2023 and Forecast, 2024-2033

  • 6.1. Historical Market Value (US$ Million) Analysis, 2019-2023
  • 6.2. Current and Future Market Value (US$ Million) Projections, 2024-2033
    • 6.2.1. Y-o-Y Growth Trend Analysis
    • 6.2.2. Absolute $ Opportunity Analysis

7. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size (US$ Million) Analysis By Product, 2019-2023
  • 7.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Product, 2024-2033
    • 7.3.1. FGF1
    • 7.3.2. FGF2
    • 7.3.3. FGF3
    • 7.3.4. FGF4
    • 7.3.5. FGF7
    • 7.3.6. FGF10
    • 7.3.7. FGF11
    • 7.3.8. FGF12
    • 7.3.9. FGF13
    • 7.3.10. FGF14
    • 7.3.11. FGF15
    • 7.3.12. FGF18
    • 7.3.13. FGF19
    • 7.3.14. FGF20
    • 7.3.15. FGF23
    • 7.3.16. Others
  • 7.4. Market Attractiveness Analysis By Product

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Application

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Million) Analysis By Application, 2019-2023
  • 8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2024-2033
    • 8.3.1. Oncology
    • 8.3.2. Hematology
    • 8.3.3. Wound Healing
    • 8.3.4. Dermatology
    • 8.3.5. Cardiovascular Disease & Diabetes
    • 8.3.6. Cell Culture
    • 8.3.7. Others
  • 8.4. Market Attractiveness Analysis By Application

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, by End User

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Million) Analysis By End User, 2019-2023
  • 9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2024-2033
    • 9.3.1. Pharmaceutical and Biotechnology Companies
    • 9.3.2. Research Centers & Academic Institutes
    • 9.3.3. CMO and CDMO
  • 9.4. Market Attractiveness Analysis By End User

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Million) Analysis By Region, 2019-2023
  • 10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Region, 2024-2033
    • 10.3.1. North America
    • 10.3.2. Latin America
    • 10.3.3. Europe
    • 10.3.4. East Asia
    • 10.3.5. South Asia
    • 10.3.6. Oceania
    • 10.3.7. Middle East and Africa (Middle East and Africa)
  • 10.4. Market Attractiveness Analysis, by Region

11. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Million) Trend Analysis, by Market Taxonomy, 2019-2023
  • 11.3. Current and Future Market Value (US$ Million) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 11.3.1. By Country
      • 11.3.1.1. United States
      • 11.3.1.2. Canada
    • 11.3.2. By Product
    • 11.3.3. By Application
    • 11.3.4. By End User
  • 11.4. Market Attractiveness Analysis
    • 11.4.1. By Country
    • 11.4.2. By Product
    • 11.4.3. By Application
    • 11.4.4. By End User
  • 11.5. Market Trends
  • 11.6. Key Market Participants - Intensity Mapping
  • 11.7. Drivers and Restraints - Impact Analysis
  • 11.8. Country Level Analysis & Forecast
    • 11.8.1. United States Market Analysis
      • 11.8.1.1. Introduction
      • 11.8.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 11.8.1.2.1. By Product
        • 11.8.1.2.2. By Application
        • 11.8.1.2.3. By End User
    • 11.8.2. Canada Market Analysis
      • 11.8.2.1. Introduction
      • 11.8.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 11.8.2.2.1. By Product
        • 11.8.2.2.2. By Application
        • 11.8.2.2.3. By End User

12. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Million) Trend Analysis, by Market Taxonomy, 2019-2023
  • 12.3. Current and Future Market Value (US$ Million) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 12.3.1. By Country
      • 12.3.1.1. Brazil
      • 12.3.1.2. Mexico
      • 12.3.1.3. Argentina
      • 12.3.1.4. Rest of Latin America
    • 12.3.2. By Product
    • 12.3.3. By Application
    • 12.3.4. By End User
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Product
    • 12.4.3. By Application
    • 12.4.4. By End User
  • 12.5. Market Trends
  • 12.6. Key Market Participants - Intensity Mapping
  • 12.7. Drivers and Restraints - Impact Analysis
  • 12.8. Country Level Analysis & Forecast
    • 12.8.1. Brazil Market Analysis
      • 12.8.1.1. Introduction
      • 12.8.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 12.8.1.2.1. By Product
        • 12.8.1.2.2. By Application
        • 12.8.1.2.3. By End User
    • 12.8.2. Mexico Market Analysis
      • 12.8.2.1. Introduction
      • 12.8.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 12.8.2.2.1. By Product
        • 12.8.2.2.2. By Application
        • 12.8.2.2.3. By End User
    • 12.8.3. Argentina Market Analysis
      • 12.8.3.1. Introduction
      • 12.8.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 12.8.3.2.1. By Product
        • 12.8.3.2.2. By Application
        • 12.8.3.2.3. By End User

13. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Million) Trend Analysis, by Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Value (US$ Million) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. Germany
      • 13.3.1.2. France
      • 13.3.1.3. Spain
      • 13.3.1.4. Italy
      • 13.3.1.5. BENELUX
      • 13.3.1.6. Russia
      • 13.3.1.7. United Kingdom
      • 13.3.1.8. Rest of Europe
    • 13.3.2. By Product
    • 13.3.3. By Application
    • 13.3.4. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Product
    • 13.4.3. By Application
    • 13.4.4. By End User
  • 13.5. Market Trends
  • 13.6. Key Market Participants - Intensity Mapping
  • 13.7. Drivers and Restraints - Impact Analysis
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. Germany Market Analysis
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.1.2.1. By Product
        • 13.8.1.2.2. By Application
        • 13.8.1.2.3. By End User
    • 13.8.2. France Market Analysis
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.2.2.1. By Product
        • 13.8.2.2.2. By Application
        • 13.8.2.2.3. By End User
    • 13.8.3. Spain Market Analysis
      • 13.8.3.1. Introduction
      • 13.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.3.2.1. By Product
        • 13.8.3.2.2. By Application
        • 13.8.3.2.3. By End User
    • 13.8.4. Italy Market Analysis
      • 13.8.4.1. Introduction
      • 13.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.4.2.1. By Product
        • 13.8.4.2.2. By Application
        • 13.8.4.2.3. By End User
    • 13.8.5. BENELUX Market Analysis
      • 13.8.5.1. Introduction
      • 13.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.5.2.1. By Product
        • 13.8.5.2.2. By Application
        • 13.8.5.2.3. By End User
    • 13.8.6. Russia Market Analysis
      • 13.8.6.1. Introduction
      • 13.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.6.2.1. By Product
        • 13.8.6.2.2. By Application
        • 13.8.6.2.3. By End User
    • 13.8.7. United Kingdom Market Analysis
      • 13.8.7.1. Introduction
      • 13.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.7.2.1. By Product
        • 13.8.7.2.2. By Application
        • 13.8.7.2.3. By End User

14. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Million) Trend Analysis, by Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Value (US$ Million) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. China
      • 14.3.1.2. Japan
      • 14.3.1.3. South Korea
    • 14.3.2. By Product
    • 14.3.3. By Application
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Application
    • 14.4.4. By End User
  • 14.5. Market Trends
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. China Market Analysis
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Product
        • 14.8.1.2.2. By Application
        • 14.8.1.2.3. By End User
    • 14.8.2. Japan Market Analysis
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Product
        • 14.8.2.2.2. By Application
        • 14.8.2.2.3. By End User
    • 14.8.3. South Korea Market Analysis
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.3.2.1. By Product
        • 14.8.3.2.2. By Application
        • 14.8.3.2.3. By End User

15. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Million) Trend Analysis, by Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Value (US$ Million) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. India
      • 15.3.1.2. Indonesia
      • 15.3.1.3. Thailand
      • 15.3.1.4. Malaysia
      • 15.3.1.5. Rest of South Asia
    • 15.3.2. By Product
    • 15.3.3. By Application
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By Application
    • 15.4.4. By End User
  • 15.5. Market Trends
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. India Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Product
        • 15.8.1.2.2. By Application
        • 15.8.1.2.3. By End User
    • 15.8.2. Indonesia Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Product
        • 15.8.2.2.2. By Application
        • 15.8.2.2.3. By End User
    • 15.8.3. Thailand Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Product
        • 15.8.3.2.2. By Application
        • 15.8.3.2.3. By End User
    • 15.8.4. Malaysia Market Analysis
      • 15.8.4.1. Introduction
      • 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.4.2.1. By Product
        • 15.8.4.2.2. By Application
        • 15.8.4.2.3. By End User

16. Oceania Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Million) Trend Analysis, by Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Value (US$ Million) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. Australia
      • 16.3.1.2. New Zealand
    • 16.3.2. By Product
    • 16.3.3. By Application
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Application
    • 16.4.4. By End User
  • 16.5. Market Trends
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. Australia Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Product
        • 16.8.1.2.2. By Application
        • 16.8.1.2.3. By End User
    • 16.8.2. New Zealand Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Product
        • 16.8.2.2.2. By Application
        • 16.8.2.2.3. By End User

17. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Million) Trend Analysis, by Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Value (US$ Million) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. GCC Countries
      • 17.3.1.2. Turkey
      • 17.3.1.3. Northern Africa
      • 17.3.1.4. South Africa
      • 17.3.1.5. Rest of Middle East and Africa
    • 17.3.2. By Product
    • 17.3.3. By Application
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Application
    • 17.4.4. By End User
  • 17.5. Market Trends
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. GCC Countries Market Analysis
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Product
        • 17.8.1.2.2. By Application
        • 17.8.1.2.3. By End User
    • 17.8.2. Turkey Market Analysis
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Product
        • 17.8.2.2.2. By Application
        • 17.8.2.2.3. By End User
    • 17.8.3. Northern Africa Market Analysis
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.3.2.1. By Product
        • 17.8.3.2.2. By Application
        • 17.8.3.2.3. By End User
    • 17.8.4. South Africa Market Analysis
      • 17.8.4.1. Introduction
      • 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.4.2.1. By Product
        • 17.8.4.2.2. By Application
        • 17.8.4.2.3. By End User

18. Market Structure Analysis

  • 18.1. Market Analysis, by Tier of Companies
  • 18.2. Market Share Analysis of Top Players
  • 18.3. Market Concentration
  • 18.4. Market Presence Analysis
    • 18.4.1. By Regional Footprint of Players
    • 18.4.2. By Product Footprint of Players
    • 18.4.3. By Channel Footprint of Players

19. Competition Analysis

  • 19.1. Competition Dashboard
  • 19.2. Key Development Analysis
  • 19.3. Branding and Promotional Strategies by Manufacturers
  • 19.4. Competition Deep Dive
    • 19.4.1. Thermo Fisher Scientific
      • 19.4.1.1. Overview
      • 19.4.1.2. Product Portfolio
      • 19.4.1.3. Sales Footprint
      • 19.4.1.4. Key Financials
      • 19.4.1.5. SWOT Analysis
      • 19.4.1.6. Key Developments
      • 19.4.1.7. Strategy Overview
        • 19.4.1.7.1. Marketing Strategy
        • 19.4.1.7.2. Product Strategy
        • 19.4.1.7.3. Channel Strategy
    • 19.4.2. Sigma-Aldrich (now part of Merck KGaA)
      • 19.4.2.1. Overview
      • 19.4.2.2. Product Portfolio
      • 19.4.2.3. Sales Footprint
      • 19.4.2.4. Key Financials
      • 19.4.2.5. SWOT Analysis
      • 19.4.2.6. Key Developments
      • 19.4.2.7. Strategy Overview
        • 19.4.2.7.1. Marketing Strategy
        • 19.4.2.7.2. Product Strategy
        • 19.4.2.7.3. Channel Strategy
    • 19.4.3. PeproTech
      • 19.4.3.1. Overview
      • 19.4.3.2. Product Portfolio
      • 19.4.3.3. Sales Footprint
      • 19.4.3.4. Key Financials
      • 19.4.3.5. SWOT Analysis
      • 19.4.3.6. Key Developments
      • 19.4.3.7. Strategy Overview
        • 19.4.3.7.1. Marketing Strategy
        • 19.4.3.7.2. Product Strategy
        • 19.4.3.7.3. Channel Strategy
    • 19.4.4. R&D Systems (a Bio-Techne brand)
      • 19.4.4.1. Overview
      • 19.4.4.2. Product Portfolio
      • 19.4.4.3. Sales Footprint
      • 19.4.4.4. Key Financials
      • 19.4.4.5. SWOT Analysis
      • 19.4.4.6. Key Developments
      • 19.4.4.7. Strategy Overview
        • 19.4.4.7.1. Marketing Strategy
        • 19.4.4.7.2. Product Strategy
        • 19.4.4.7.3. Channel Strategy
    • 19.4.5. Abcam
      • 19.4.5.1. Overview
      • 19.4.5.2. Product Portfolio
      • 19.4.5.3. Sales Footprint
      • 19.4.5.4. Key Financials
      • 19.4.5.5. SWOT Analysis
      • 19.4.5.6. Key Developments
      • 19.4.5.7. Strategy Overview
        • 19.4.5.7.1. Marketing Strategy
        • 19.4.5.7.2. Product Strategy
        • 19.4.5.7.3. Channel Strategy
    • 19.4.6. Cell Signaling Technology
      • 19.4.6.1. Overview
      • 19.4.6.2. Product Portfolio
      • 19.4.6.3. Sales Footprint
      • 19.4.6.4. Key Financials
      • 19.4.6.5. SWOT Analysis
      • 19.4.6.6. Key Developments
      • 19.4.6.7. Strategy Overview
        • 19.4.6.7.1. Marketing Strategy
        • 19.4.6.7.2. Product Strategy
        • 19.4.6.7.3. Channel Strategy
    • 19.4.7. Novus Biologicals
      • 19.4.7.1. Overview
      • 19.4.7.2. Product Portfolio
      • 19.4.7.3. Sales Footprint
      • 19.4.7.4. Key Financials
      • 19.4.7.5. SWOT Analysis
      • 19.4.7.6. Key Developments
      • 19.4.7.7. Strategy Overview
        • 19.4.7.7.1. Marketing Strategy
        • 19.4.7.7.2. Product Strategy
        • 19.4.7.7.3. Channel Strategy

20. Assumptions and Acronyms Used

21. Research Methodology